Dr. Phillip Low is Robert D and Patricia E Kern Professor of Neurology. His training and interests in autonomic testing and autonomic disorders began in Australia. He has been at Mayo Clinic, Rochester, Minnesota since 1976. At Mayo, he founded the Mayo Clinical Autonomic Laboratory in 1983. He headed an Autonomic Disorders Program Project followed by MSA Program Project and was PI of a randomized clinical trial of Rifampicin in MSA. His recent research, with Wolfgang Singer, has focused on biomarkers specific to MSA and phenoconversion of prodromal and preclinical MSA. The goal is to identify early, prodromal and preclinical MSA and couple that approach with finding effective treatment to slow/reverse progression of MSA.
Thu, Sep 30, 2021
3:30 PM - 4:00 PM EDT
View Welcome Remarks RecordingView Fireside Chat Recording